详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Triptolide reverses MCF-7/ADR cell resistance by down-regulating P-glycoprotein expression

文献详情

资源类型：

作者：

机构： [1]Department of Breast Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

出处：

ISSN：

关键词： Drug resistance Drug-resistant human breast cancer cell P-glycoprotein Triptolide

摘要：

Objective: To explore the reversal effects of triptolide (TP) on drug-resistance of adriamycin (Adriacin doxorubicin, ADR)-resistant human breast cancer cell lines (MCF-7/ADR) in vivo and in vitro. Methods: effects of triptolide and adriamycin on MCF-7 and MCF-7/ADR cell proliferation was measured by CCK-8, the reversal effect of triptolide on the drug-resistance of MCF-7/ADR cells was also measured by CCK-8; flow cytometer for testing the effect of triptolide and adriamycin on cell apoptosis was detected by flow cytometer; the expression level of P-glycoprotein was determined by Western blotting. Results: Different concentrations of adriamycin and triptolide at had inhibitory effects on the viability of MCF-7 and MCF-7/ADR cells respectively, with a concentration-dependent manner. To be specific, IC50 values of adriamycin on MCF-7 and MCF-7/ADR cells were 110.6±2.6 and 806.9±4.6 μg/ml, respectively, with an resistance index of 7.29. The IC50 values of triptolide on MCF-7 and MCF-7/ADR cells were 330.5±3.5 and 345.2±2.8 nmol/L, respectively, with a resistance index of 1.04. A combination of triptolide at non-toxic dosage levels with adriamycin reversed the drug resistance of MCF-7/ADR, with a reversal fold up to 3.65±0.21, induced cell apoptosis of MCF-7 and MCF-7/ADR, and could also significantly inhibit the growth of subcutaneous MCF-7/ADR tumor, as well as down-regulated the expression of P-glycoprotein in tumor cells in vitro and in vivo. Conclusions: Triptolide can significantly reverse the resistance of MCF-7/ADR cells, and P-glycoprotein is involved in regulating the drug-resistant effects of MCF-7/ADR cells. © 2017, E-Century Publishing Corporation. All rights reserved.

语种：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 4 区医学

小类 | 4 区医学：研究与实验

最新[2023]版：

无

第一作者：

第一作者机构： [1]Department of Breast Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

通讯作者：

通讯机构： [1]Department of Breast Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [*1]Department of Breast Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Triptolide reverses MCF-7/ADR cell resistance by down-regulating P-glycoprotein expression [2]Triptolide reverses MCF-7/ADR cell resistance by down-regulating P-glycoprotein expression [3]Degradation of P-glycoprotein by pristimerin contributes to overcoming ABCB1-mediated chemotherapeutic drug resistance in vitro [4]Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals [5]辣椒素对多柔比星耐药的乳腺癌细胞的耐药逆转作用 [6]HDAC2 was involved in placental P-glycoprotein regulation both in vitro and vivo. [7]Nanomedicine Combats Drug Resistance in Lung Cancer [8]HDAC2 was involved in placental P-glycoprotein regulation both in vitro and vivo. [9]Protein degradation: expanding the toolbox to restrain cancer drug resistance [10]Editorial: Non-genetic adaptive drug resistance in cancer